Alpine Partners VI »

Nurix Therapeutics shares owned by Alpine Partners VI

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Alpine Partners VI from 13F filings

Historical chart of Alpine Partners VI investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Alpine Partners VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Alpine Partners VI

Quarter filed Position value Share count Share price at filing
2024-06-30 $265k 13k 20.87
2022-12-31 $121k 11k 11.01

More positions owned by Alpine Partners VI

Immunovant (IMVT)
Cornerstone Strategic Value (CLM)
Robinhood Mkts Com Cl A (HOOD)
Cornerstone Total Rtrn Fd In (CRF)
Archer Aviation Com Cl A (ACHR)
Blackrock Muni Intermediate Drtn Fnd (MUI)
Burlington Stores Note 2.250% 4/1
Redfin Corp Note 0.500% 4/0
Blackrock Capital Allocation Trust (BCAT)
Rivian Automotive Note 4.625% 3/1
Stericycle (SRCL)
Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Pagaya Technologies Cl A New (PGY)
Jazz Investments I Note 2.000% 6/1
ON Semiconductor (ON)

View all positions for Alpine Partners VI

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Vanguard Group
Baker Bros. Advisors
Deep Track Capital
Wellington Management Company
T. Rowe Price Associates
T. Rowe Price Investment Management
State Street Corporation
ARK Investment Management
Pictet Asset Management Holding SA
Commodore Capital
Citadel Advisors
Geode Capital Management
Driehaus Capital Management

View all funds holding Nurix Therapeutics